Co-Diagnostics Profit Margin

The latest profit margin for CODX is -6523.04% as of June 2026. That compares with -3586.0% in the prior-year period — down 81.9% year over year. That is below the Healthcare sector average of 13.45%. Investors often review this figure alongside Co-Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CODX's profit margin moved from -3586.0% to -6523.04% — a 81.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Co-Diagnostics's valuation or profitability profile.

Against Healthcare companies, CODX currently prints -6523.04% for profit margin, while the sector average sits near 13.45%. That is roughly 48606.4% below the sector mean. Large gaps often invite a closer look at Co-Diagnostics's growth, margins, and balance sheet.

Profit Margin shows how effectively Co-Diagnostics converts resources into returns. At -6523.04%, CODX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3586.0% in the prior-year period — down 81.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CODX's profit margin (-6523.04%), review year-over-year change from -3586.0%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.